THE EFFECT OF INCREASED ALTITUDE ON RECOMBINANT ERYTHROPOIETIN (EPO) DOSING AND ACHIEVED HEMATOCRIT LEVELS IN END-STAGE RENAL DISEASE

被引：0
|
作者：
Brookhart, M. Alan [1 ]
Bradbury, B. D. [1 ]
Winkelmayer, W. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02120 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2009年 / 169卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [21] TREATMENT WITH ERYTHROPOIETIN IN END-STAGE RENAL-DISEASE
    SCHAFER, R
    KRAMER, W
    SOETANTO, R
    WIZEMANN, V
    SCHUTTERLE, G
    MEDIZINISCHE WELT, 1990, 41 (09): : 795 - 800
  • [22] EFFECT OF ERYTHROPOIETIN (EPO) TREATMENT ON BLOOD LIPID PROFILE IN END-STAGE RENAL-FAILURE (ESRF)
    POLLOCK, CA
    WYNDHAM, R
    COLLETT, P
    ELDER, G
    FIELD, MJ
    GEORGE, CRP
    KALOWSKI, S
    LAWRENCE, JR
    WAUGH, D
    KIDNEY INTERNATIONAL, 1994, 45 (04) : 1253 - 1253
  • [23] Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease
    Boran, M
    Dalva, I
    Gonenc, F
    Cetin, S
    NEPHRON, 1996, 73 (02): : 314 - 315
  • [24] COST IMPLICATIONS TO MEDICARE OF RECOMBINANT ERYTHROPOIETIN THERAPY FOR THE ANEMIA OF END-STAGE RENAL-DISEASE
    POWE, NR
    GRIFFITHS, RI
    BASS, EB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (10): : 1660 - 1671
  • [25] Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients
    Cody, J
    Daly, C
    Campbell, M
    Donaldson, C
    Khan, I
    Vale, L
    Wallace, S
    MacLeod, A
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03):
  • [26] Effect of altitude on mortality of end-stage renal disease patients on hemodialysis in Peru
    Bravo-Jaimes, Katia
    Loescher, Viky Y.
    Canelo-Aybar, Carlos
    Rojas-Camayo, Jose
    Mejia, Christian R.
    Schult, Sandra
    Nieto, Ruben
    Singh, Kyra
    Messing, Susan
    Hinostroza, Juana
    CLINICAL KIDNEY JOURNAL, 2021, 14 (03) : 998 - 1003
  • [27] Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
    Khankin, Eliyahu V.
    Mutter, Walter P.
    Tamez, Hector
    Yuan, Hai-Tao
    Karumanchi, S. Ananth
    Thadhani, Ravi
    PLOS ONE, 2010, 5 (02):
  • [28] INCREASED PLASMA LIPOPROTEIN(A) LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    DIEPLINGER, H
    LACKNER, C
    KONIG, P
    UTERMANN, G
    ARTERIOSCLEROSIS, 1990, 10 (05): : A860 - A860
  • [29] Candidate biomarkers for erythropoietin response in end-stage renal disease
    Besarab, Anatole
    Yee, Jerry
    KIDNEY INTERNATIONAL, 2011, 79 (05) : 488 - 490
  • [30] ACUTE EFFECT OF ERYTHROPOIETIN ON PLASMA-RENIN ACTIVITY AND ALDOSTERONE LEVELS IN END-STAGE RENAL-DISEASE
    ARIK, N
    DEMIRKAN, F
    ERBAS, B
    ARINSOY, T
    SUNGUR, C
    YASAVUL, U
    TURGAN, C
    KORAY, Z
    CAGLAR, S
    NEPHRON, 1992, 60 (01): : 111 - 111
12345